Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short‐term outcomes after liver transplantation—A systematic review of the literature and expert panel recommendations
Clinical Transplantation2022Vol. 36(10), pp. e14637–e14637
Citations Over TimeTop 10% of 2022 papers
Uzung Yoon, Justyna Bartoszko, Dmitri Bezinover, Gíanni Biancofiore, Katherine T. Forkin, Suehana Rahman, Michael Spiro, Dimitri Aristotle Raptis, Yoogoo Kang, the ERAS4OLT.org Working Group
Abstract
Q1: A specific blood product transfusion practice is not recommended (QOE; low | Recommendation; weak). Cell salvage and educational interventions are recommended (QOE: low | Grade of Recommendation: moderate). Q2: The routine use of antifibrinolytics is not recommended (QOE; low | Recommendation; weak). Q3: The use of VET is recommended (QOE; low-moderate | Recommendation; strong).
Related Papers
- → Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery(1986)122 cited
- → Antifibrinolytics in women with menorrhagia(2011)21 cited
- → Efectividad de ácido tranexámico en prótesis total de rodilla en la práctica clínica habitual(2008)12 cited
- → TRAUMATIC HYPHAEMA TREATED WITH THE ANTIFIBRINOLYTIC DRUG TRANEXAMIC ACID II(1977)18 cited
- Mechanism and clinical application of tranexamic acid in treating menorrhagia(2013)